Propel Holdings. Buy, Sell or Hold?

Roth Capital Markets analyst Craig Irwin says Propel Holdings (Propel Holdings Stock Quote, Chart, News, Analysts, Financials TSX:PRL) continues to post record results despite an unfavourable macro backdrop, with improving credit trends and a major new product launch setting up material growth in 2026.

In a Nov. 21 report, Irwin reiterated his “Buy” rating and C$35.00 price target after hosting CEO Clive Kinross at the firm’s 14th Annual ROTH Technology Conference.

Propel Holdings, a Toronto-based fintech lender, delivered 19% organic revenue growth and 37% origination growth in the third quarter of 2025, even as the company and its bank partners tightened underwriting in response to inflation-driven delinquency pressure. Third-quarter originations reached a record US$205.3-million, up from US$194.4-million in Q2 and US$150-million a year earlier. Irwin said U.S. consumer credit trends have improved in early Q4, with metrics now back within historical ranges.

“PRL continues to execute and deliver record results, amid an unfavourable macro,” he said.

Propel is preparing to launch its second Lending-as-a-Service product in the first quarter of 2026 with Column N.A., a nationally chartered U.S. bank founded by Plaid co-founder William Hockey. The product, Freshline, Provided by Column, will use Propel as loan servicer and will forward the economics of originated loans to third-party partners.

Irwin said management expects the LaaS business to grow “as much as 100% in 2026,” driven by the new partnership. Column’s existing fintech clients include Brex, Bilt and Wise.

Irwin also expects Propel’s U.K.-based QuidMarket unit to gain share next year. The company has finished integrating finance, corporate and IT functions and is implementing product upgrades, including risk-based pricing. Management sees a favourable competitive landscape in the U.K., given tight consumer credit supply and a highly fragmented market. Irwin said Propel expects QuidMarket to grow revenue by more than 50% in 2025, with further acceleration in 2026.

He left his estimates unchanged but reiterated his C$35 target, which is based on a 7× EV/EBITDA multiple applied to fiscal 2026 estimated EBITDA.

Irwin expects Propel to generate about US$145.6-million of Adjusted EBITDA on US$595-million of revenue in fiscal 2025, increasing to US$185-million on US$755-million in fiscal 2026.

-30-

Tagged with: prl
Rod Weatherbie

Rod Weatherbie is a journalist based in Prince Edward Island. Since 2004, he has written extensively about the Canadian property and casualty insurance landscape. He was also a founder and contributing editor for a Toronto-based arts website and a PEI-based food magazine. His fiction and poetry have been featured in The Fiddlehead, The Antigonish Review, and Juniper.

Recent Posts

Tilray: why this analyst just cut his price target

Haywood Securities analyst Neal Gilmer says lower Canadian cannabis market share is weighing on Tilray Brands (Tilray Brands Stock Quote,… [Read More]

8 hours ago

Why National Bank likes Anaergia right now

National Bank Financial analyst Baltej Sidhu says Anaergia’s (Anaergia Stock Quote, Chart, News, Analysts, Financials TSX:ANRG) divestiture of two legacy… [Read More]

8 hours ago

Canada’s provinces are leading investment boom, RBC says

RBC assistant chief economist Cynthia Leach says the public sector is playing a larger role in Canada’s investment boom than… [Read More]

8 hours ago

Can Eupraxia Pharmaceuticals stock go even higher?

Research Capital analyst Andre Uddin says Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:EPRX) reported another strong… [Read More]

8 hours ago

Is it time to buy VersaBank stock?

Roth Capital Partners analyst Craig Irwin says VersaBank (VersaBank Stock Quote, Chart, News, Analysts, Financials NASDAQ:VBNK) is nearing a potential… [Read More]

8 hours ago

Rapid Micro Biosystems has a 240% upside, this analyst says

Roth Capital Partners analyst Max Masucci says Rapid Micro Biosystems (Rapid Micro Biosystems Stock Quote, Chart, News, Analysts, Financials NASDAQ:RPID)… [Read More]

8 hours ago